References
- Advisory Council on the Misuse of Drugs. Home Office Report: Reducing Drug Related Deaths. Stationery Office, London 2000
- Browns B. S., Benn G. J., Jansen D. R. Methadone maintenance: Some client opinions. American Journal of Psychiatry 1975; 132((6))623–626
- Fischer B., Chin A. T., Kuo M., Vlahov D. Canadian illicit opiate users views on methadone and other opiate prescription treatment: an exploratory qualitative study. Substance Use and Misuse 2002; 37((4))495–522
- Hunt D. E., Lipton D. S., Goldsmith D. S., Strug D. L., Spunt B. ‘It takes your heart out’: the image of methadone maintenance in the addict world and its effect on recruitment in to treatment. International Journal of the Addictions 1985; 20(11–12): 1751–1771
- Luty J., O'Gara C., Sessay M. Is methadone too dangerous for opiate addiction?. British Medical Journal 2005; 331: 1352–1353
- Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: A meta‐analysis. Addiction 1998; 93((4))515–532
- Mattick R. P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). The Cochrane library 2003, issue 2
- Millar T., Gemmell I., Hay G., Donmall N. The dynamics of drug misuse: Assessing changes in prevalence. Home Office, London 2004, Home Office Online Report 35/04
- Pani P. P., Maremmani I., Pirastu R., Tagliamonte A. Buprenorphine: A controlled trial in the treatment of opioid dependence. Drug and Alcohol Dependence 2000; 60: 39–50
- Petitjean S., Stohler R., Deglon J., Livoti S., Waldvogel D., Uehlinger C., Ladewig D. Double‐blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence 2001; 62: 97–104
- Pinto H., Rumball D., Maskrey V., Holland R. A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients. Journal of Substance Use 2008; 13((1))73–82
- Rosenblum A., Magura S., Joseph H. Ambivalence towards methadone treatment among intravenous drug users. Journal of Psychoactive Drugs 1991; 23((1))21–27
- Stancliff S., Myers J. E., Steiner S., Drucker E. Beliefs about methadone in an Inner City methadone Clinic. Journal of Urban Health 2002; 79((4))571–578
- Walsh S. L., Preston K. L., Stitzer M. L., Cone E. J., Bigelow G. E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clinical Pharmacology and Therapy 1994; 55((5))569–580
- Zule W. A., Desmond D. P. Attitudes towards methadone maintenance: Implications for HIV prevention. Journal of Psychoactive Drugs 1998; 30((1))89–97